Olian Judy D. 4

What Happened

• Judy D. Olian, a director of United Therapeutics (UTHR), sold 200 shares of company stock in an open-market transaction on March 6, 2026.
• The shares were sold at $510.00 each, generating proceeds of $102,000.
• This was a sale (not a purchase); sales can be routine and do not necessarily indicate a change in confidence.

Key Details

• Transaction date: 2026-03-06
• Price per share: $510.00; Total proceeds: $102,000
• Form filed with SEC: Accession 0001605729-26-000004, filed 2026-03-09
• Shares owned after transaction: not specified in the provided filing excerpt
• Footnote: Sale executed pursuant to a pre-arranged 10b5-1 trading plan established by Ms. Olian on November 24, 2025

Context

• A 10b5-1 plan allows insiders to sell shares according to a preset schedule and is intended to reduce the chance the trade reflects non-public, current information; such trades are generally seen as routine.
• Sales are less informative about future performance than purchases; this filing documents a small, scheduled disposition by a director rather than a large, opportunistic stake change.